The story of Viagra, and its parent company copyright, presents a intriguing case study for investors. Originally a blockbuster drug, yielding billions in income, its patent expiration created a flood of lower-priced alternatives , significantly diminishing its position . While some businesses may attempt to capitalize on related treatments , the c